CN104694560A - Disulfide bond isomerase gene Trpdi2 from Trichoderma reesei and application thereof - Google Patents
Disulfide bond isomerase gene Trpdi2 from Trichoderma reesei and application thereof Download PDFInfo
- Publication number
- CN104694560A CN104694560A CN201310651365.6A CN201310651365A CN104694560A CN 104694560 A CN104694560 A CN 104694560A CN 201310651365 A CN201310651365 A CN 201310651365A CN 104694560 A CN104694560 A CN 104694560A
- Authority
- CN
- China
- Prior art keywords
- disulfide bond
- bond isomerase
- polynucleotide sequence
- trichoderma reesei
- trpdi2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000769 Isomerases Proteins 0.000 title claims abstract description 58
- 241000499912 Trichoderma reesei Species 0.000 title claims abstract description 29
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 29
- 239000002157 polynucleotide Substances 0.000 claims abstract description 29
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 29
- 102000004195 Isomerases Human genes 0.000 claims abstract description 27
- 239000002299 complementary DNA Substances 0.000 claims abstract description 12
- 230000000295 complement effect Effects 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 59
- 102000004169 proteins and genes Human genes 0.000 claims description 48
- 230000000694 effects Effects 0.000 claims description 35
- 239000013604 expression vector Substances 0.000 claims description 17
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 16
- 230000014509 gene expression Effects 0.000 claims description 15
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 5
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 abstract description 3
- 125000003729 nucleotide group Chemical group 0.000 abstract description 3
- 235000018102 proteins Nutrition 0.000 description 37
- 101150052795 cbh-1 gene Proteins 0.000 description 17
- 229940088598 enzyme Drugs 0.000 description 15
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 241000233866 Fungi Species 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000006664 bond formation reaction Methods 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 230000004481 post-translational protein modification Effects 0.000 description 3
- 230000004952 protein activity Effects 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- NMPZCCZXCOMSDQ-XVFCMESISA-N 2',3'-cyclic CMP Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H]2OP(O)(=O)O[C@@H]2[C@@H](CO)O1 NMPZCCZXCOMSDQ-XVFCMESISA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- 108010084185 Cellulases Proteins 0.000 description 2
- 102000005575 Cellulases Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 2
- 101710112457 Exoglucanase Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- WCPTXJJVVDAEMW-UHFFFAOYSA-N cCMP Natural products O=C1N=C(N)C=CN1C1C(O)C2OP(O)(=O)OCC2O1 WCPTXJJVVDAEMW-UHFFFAOYSA-N 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
- 235000021472 generally recognized as safe Nutrition 0.000 description 2
- 229960000789 guanidine hydrochloride Drugs 0.000 description 2
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101000609839 Dictyostelium discoideum Protein disulfide-isomerase 2 Proteins 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000735558 Homo sapiens Protein-arginine deiminase type-2 Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 1
- 102100035735 Protein-arginine deiminase type-2 Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 150000001945 cysteines Chemical class 0.000 description 1
- 239000005549 deoxyribonucleoside Substances 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000003600 isomerase activity assay Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 108020003519 protein disulfide isomerase Proteins 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 230000005892 protein maturation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002342 ribonucleoside Substances 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
本发明公开了一种源于里氏木霉的二硫键异构酶基因Trpdi2及其用途,本发明从里氏木霉(Trichoderma reesei)中所分离的二硫键异构酶基因,其多核苷酸序列为(a)或(b)所示:(a)SEQ ID No.1所示的多核苷酸序列;(b)与(a)中多核苷酸序列根据碱基互补配对原则互补的多核苷酸序列以及(c)SEQ ID NO.1所示的多核苷酸序列(a)或(b)中多核苷酸序列的cDNA的序列:为SEQ ID NO.2所示的多核苷酸序列。本发明还从里氏木霉中所分离的二硫键异构酶基因编码获得二硫键异构酶并验证了二硫键异构酶的应用。
The invention discloses a disulfide bond isomerase gene Trpdi2 derived from Trichoderma reesei and its application. The disulfide bond isomerase gene isolated from Trichoderma reesei in the present invention has a The nucleotide sequence is shown in (a) or (b): (a) the polynucleotide sequence shown in SEQ ID No.1; (b) is complementary to the polynucleotide sequence in (a) according to the principle of base complementary pairing Polynucleotide sequence and (c) the sequence of the polynucleotide sequence shown in SEQ ID NO.1 (a) or the cDNA sequence of the polynucleotide sequence in (b): the polynucleotide sequence shown in SEQ ID NO.2 . The invention also obtains the disulfide bond isomerase from the coded disulfide bond isomerase gene isolated from Trichoderma reesei and verifies the application of the disulfide bond isomerase.
Description
技术领域technical field
本发明涉及生物化工和微生物基因工程领域,特别涉及一种源于里氏木霉的二硫键异构酶基因Trpdi2及其用途。The invention relates to the fields of biochemical engineering and microbial genetic engineering, in particular to a disulfide bond isomerase gene Trpdi2 derived from Trichoderma reesei and its application.
背景技术Background technique
由于纤维素酶资源及其纤维素酶生产能力,丝状真菌在过去的几十年受到了极大的关注,但是随着工业及生物医药的发展,人们希望利用具有强大的分泌能力的丝状真菌作为细胞工厂,更高效地生产内源及外源蛋白。Due to the cellulase resources and their cellulase production capacity, filamentous fungi have received great attention in the past few decades, but with the development of industry and biomedicine, people hope to use filamentous fungi with strong secretion ability Fungi act as cell factories to more efficiently produce endogenous and exogenous proteins.
相对于其他的表达受体,丝状真菌作为外源蛋白的表达受体具有较大优势。相对于原核表达宿主,丝状真菌能够对外源蛋白进行如二硫键形成、糖基化、蛋白酶切割等翻译后加工过程;相对于酵母,丝状真菌的糖基化作用与哺乳动物更接近,能够避免酵母对于外源蛋白的过度糖基化;相对于哺乳动物细胞、昆虫等高等生物表达系统,丝状真菌具有生长速度快、成本更低、更易于形成规模等优势(钟耀华等,2010)。另外工业丝状真菌如里氏木霉、黑曲霉、和米曲霉等已被美国食品和药品管理局认定为GRAS(GenerallyRecognized as Safe)和食品添加剂范围的菌株,保证了其作为宿主菌株的安全性(张建军等,2009;刘德辉等,2010)。Compared with other expression receptors, filamentous fungi have greater advantages as expression receptors of foreign proteins. Compared with prokaryotic expression hosts, filamentous fungi can perform post-translational processing of foreign proteins such as disulfide bond formation, glycosylation, and protease cleavage; compared with yeast, the glycosylation of filamentous fungi is closer to that of mammals. It can avoid excessive glycosylation of foreign proteins by yeast; compared with mammalian cells, insects and other higher biological expression systems, filamentous fungi have the advantages of fast growth, lower cost, and easier scale formation (Zhong Yaohua et al., 2010) . In addition, industrial filamentous fungi such as Trichoderma reesei, Aspergillus niger, and Aspergillus oryzae have been identified as GRAS (Generally Recognized as Safe) and food additive strains by the US Food and Drug Administration, ensuring their safety as host strains (Zhang Jianjun et al., 2009; Liu Dehui et al., 2010).
其中,里氏木霉作为工业上广泛应用的菌株,自身蛋白分泌可以达到100g/L,但是作为宿主表达外源蛋白,产量只是维持在毫克水平,这主要是由于转录、翻译、翻译后修饰及分泌等多水平因素限制造成的(Nevalainen等,2005)。为了克服这些限制,人们也进行了一些工作,主要集中在使用强启动子、增加基因拷贝数、与内源基因融合表达等转录水平的操作上,虽然结果显示产物有一定程度的增加,但是有限的提高程度也表示转录水平并不是主要的限制因素,目前的主要研究开始转向翻译后过程。Among them, Trichoderma reesei is widely used in industry, and its own protein secretion can reach 100g/L, but as a host to express foreign protein, the output is only maintained at the milligram level, which is mainly due to transcription, translation, post-translational modification and It is caused by the restriction of multi-level factors such as secretion (Nevalainen et al., 2005). In order to overcome these limitations, people have also carried out some work, mainly focusing on the operation of transcription level such as using strong promoters, increasing gene copy number, and fusion expression with endogenous genes. Although the results show that the product has increased to a certain extent, it is limited. The degree of improvement also indicates that the level of transcription is not the main limiting factor, and the current major research is turning to post-translational processes.
在自身及外源蛋白被翻译后至分泌到胞外的过程中,会受到蛋白质的质量监控,只有正确折叠并具有正确结构的蛋白质才能被成功分泌(Saloheimo等,2012)。而二硫键的形成在蛋白质折叠过程中极其重要。二硫键是蛋白质多肽链内或链间两个半胱氨酸之间共价连接键,它的形成是氧化型蛋白质折叠和成熟过程中的重要步骤,它可以提高蛋白质的稳定性,降低蛋白酶对蛋白质的降解,并对蛋白质的结构及生物活性有重要影响。二硫键对蛋白质活性的影响机理主要分为三种:1.形成二硫键的半胱氨酸是酶的活性位点,其氧化还原状态决定酶的催化反应;2.二硫键靠近活性部位,通过影响酶活性中心基团的去向影响酶活性;3.通过二硫键维持蛋白质的特定构象以保证功能(王亮等,2011)。很多证据证实二硫键可以在体外自发形成,但是其速度远低于体内反应,因为体内二硫键的形成过程是在酶的催化作用下,通过电子在半胱氨酸和二硫键之间的传递实现的。存在于内质网上的二硫键异构酶系统负责里氏木霉中的二硫键形成,对于里氏木霉蛋白质的成熟十分重要。During the process of self and foreign proteins being translated and secreted outside the cell, the quality of the protein will be monitored, and only correctly folded proteins with the correct structure can be successfully secreted (Saloheimo et al., 2012). The formation of disulfide bonds is extremely important in the protein folding process. Disulfide bond is a covalent link between two cysteines in a protein polypeptide chain or between chains. Its formation is an important step in the folding and maturation of oxidized proteins. It can improve protein stability and reduce proteases. It can degrade protein and have important influence on the structure and biological activity of protein. The mechanism of the influence of disulfide bonds on protein activity is mainly divided into three types: 1. The cysteine that forms the disulfide bond is the active site of the enzyme, and its redox state determines the catalytic reaction of the enzyme; 2. The disulfide bond is close to the activity 3. Maintain the specific conformation of the protein through the disulfide bond to ensure the function (Wang Liang et al., 2011). A lot of evidence has confirmed that disulfide bonds can be formed spontaneously in vitro, but the speed is much lower than that of in vivo reactions, because the formation of disulfide bonds in vivo is catalyzed by enzymes, and electrons are passed between cysteine and disulfide bonds. The transmission is realized. The disulfide isomerase system present on the endoplasmic reticulum is responsible for disulfide bond formation in T. reesei and is important for the maturation of T. reesei proteins.
当大量表达内源或外源蛋白时,里氏木霉翻译后过程负荷过重,导致内质网工具酶酶量的相对缺乏,会造成蛋白的错误折叠装配。而通过表达二硫键异构酶基因,可以提高蛋白质成熟过程中二硫键形成的能力,最终增加外源蛋白产量(Sha等,2013;Mukaiyama等,2010)。所以鉴定、克隆高活力的二硫键异构酶基因,可以为增加里氏木霉表达外源蛋白的能力,及体外恢复二硫键必需蛋白的活性提供工具。When a large amount of endogenous or exogenous proteins are expressed, the post-translational process of Trichoderma reesei is overloaded, resulting in a relative lack of enzymes in the endoplasmic reticulum, which will cause protein misfolding and assembly. By expressing the disulfide bond isomerase gene, the ability of disulfide bond formation during protein maturation can be improved, and finally the production of exogenous protein can be increased (Sha et al., 2013; Mukaiyama et al., 2010). Therefore, the identification and cloning of highly active disulfide bond isomerase genes can provide tools for increasing the ability of Trichoderma reesei to express foreign proteins and restoring the activity of disulfide bond essential proteins in vitro.
发明内容Contents of the invention
本发明的目的之一是提供一种源于里氏木霉的二硫键异构酶基Trpdi2。One of the objectives of the present invention is to provide a disulfide bond isomerase-based Trpdi2 derived from Trichoderma reesei.
本发明的目的之二是提供含有上述源于里氏木霉的二硫键异构酶基因Trpdi2的表达载体及重组宿主细胞。The second object of the present invention is to provide an expression vector and a recombinant host cell containing the above-mentioned disulfide bond isomerase gene Trpdi2 derived from Trichoderma reesei.
本发明的目的之三是提供源于里氏木霉的二硫键异构酶基因Trpdi2所编码的二硫键异构酶的用途。The third object of the present invention is to provide the use of the disulfide bond isomerase encoded by the disulfide bond isomerase gene Trpdi2 derived from Trichoderma reesei.
本发明公开了一种从里氏木霉中(Trichoderma reesei)所分离的二硫键异构酶基因,其特征在于,其多核苷酸序列为(a)或(b)所示:The invention discloses a disulfide bond isomerase gene isolated from Trichoderma reesei, characterized in that its polynucleotide sequence is shown in (a) or (b):
(a)SEQ ID No.1所示的多核苷酸序列;(a) the polynucleotide sequence shown in SEQ ID No.1;
(b)与(a)中多核苷酸序列根据碱基互补配对原则互补的多核苷酸序列。(b) A polynucleotide sequence complementary to the polynucleotide sequence in (a) according to the principle of complementary base pairing.
优选的是,其多核苷酸序列还为(c)所示:Preferably, its polynucleotide sequence is also shown in (c):
(c)SEQ ID NO.1所示的多核苷酸序列(a)或(b)中多核苷酸序列的cDNA的序列:为SEQ ID NO.2所示的多核苷酸序列。(c) The polynucleotide sequence shown in SEQ ID NO.1 (a) or the cDNA sequence of the polynucleotide sequence in (b): the polynucleotide sequence shown in SEQ ID NO.2.
一种由如权利要求1所述的从里氏木霉中(Trichoderma reesei)所分离的二硫键异构酶基因所编码的二硫键异构酶。A disulfide bond isomerase encoded by the disulfide bond isomerase gene isolated from Trichoderma reesei as claimed in claim 1.
优选的是,所述的二硫键异构酶其氨基酸序列为SEQ ID NO.3所示的氨基酸序列。Preferably, the amino acid sequence of the disulfide bond isomerase is the amino acid sequence shown in SEQ ID NO.3.
一种含有如权利要求1所述的从里氏木霉中(Trichoderma reesei)所分离的二硫键异构酶基因的表达载体。所述表达载体为在细菌或真菌中表达外源基因的重组表达载体以及含有该重组表达载体的重组宿主菌株或转化体;该重组表达载体包括:启动子、本发明所述的二硫键异构酶基因多核苷酸序列以及终止子;其中,二硫键异构酶基因多核苷酸序列位于启动子下游,终止子位于待转录的外源基因序列的下游。An expression vector containing the disulfide bond isomerase gene isolated from Trichoderma reesei as claimed in claim 1. The expression vector is a recombinant expression vector for expressing foreign genes in bacteria or fungi and a recombinant host strain or transformant containing the recombinant expression vector; the recombinant expression vector includes: a promoter, a disulfide bond heterogeneous The polynucleotide sequence of the isomerase gene and the terminator; wherein, the polynucleotide sequence of the disulfide bond isomerase gene is located downstream of the promoter, and the terminator is located downstream of the exogenous gene sequence to be transcribed.
一种含有权利要求1所述二硫键异构酶基因的表达载体的重组宿主细胞。A recombinant host cell containing the expression vector of the disulfide bond isomerase gene according to claim 1.
优选的是,所述的二硫键异构酶在提高内源或者外源蛋白表达的应用。Preferably, the application of the disulfide bond isomerase to increase the expression of endogenous or exogenous proteins.
优选的是,所述的二硫键异构酶在稳定和恢复二硫键必需酶活性中的应用。Preferably, the disulfide bond isomerase is used in stabilizing and restoring disulfide bond essential enzyme activity.
本发明的有益效果是本发明利用生物学方法包括体外表达蛋白和蛋白活性测定证明了里氏木霉中有一个对二硫键形成具有重要作用的基因Trpdi2,并明确了基因Trpdi2的多核苷酸序列,以及其cDNA的多核苷酸序列,并提供了源于里氏木霉的二硫键异构酶基因编码的二硫键异构酶的氨基酸序列;所述二硫键异构酶可以在体外催化不同来源蛋白的二硫键形成,是一种新型的二硫键异构酶。所述二硫键异构酶还可以用来体外恢复或保持二硫键必需酶的活性,并可以用于提高里氏木霉表达外源蛋白的产量。The beneficial effect of the present invention is that the present invention proves that there is a gene Trpdi2 that plays an important role in disulfide bond formation in Trichoderma reesei by using biological methods including in vitro protein expression and protein activity assay, and the polynucleotide of the gene Trpdi2 is clarified sequence, and the polynucleotide sequence of its cDNA, and provides the amino acid sequence of the disulfide bond isomerase derived from the disulfide bond isomerase gene coded by Trichoderma reesei; the disulfide bond isomerase can be found in It catalyzes the disulfide bond formation of proteins from different sources in vitro, and is a new type of disulfide bond isomerase. The disulfide bond isomerase can also be used to restore or maintain the activity of disulfide bond essential enzymes in vitro, and can be used to improve the yield of exogenous protein expressed by Trichoderma reesei.
本发明所涉及到的术语定义Definition of terms involved in the present invention
除非另外定义,否则本文所用的所有技术及科学术语都具有与本发明所属领域的普通技术人员通常所了解相同的含义。虽然在本发明的实践或测试中可使用与本文所述者类似或等效的任何方法、装置和材料,但现在描述优选方法、装置和材料。Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods, devices and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods, devices and materials are now described.
术语“碱基互补配对原则”意指在DNA分子结构中,由于碱基之间的氢键具有固定的数目和DNA两条链之间的距离保持不变,使得碱基配对必须遵循一定的规律,这就是Adenine(A,腺嘌呤)一定与Thymine(T,胸腺嘧啶)配对,Guanine(G,鸟嘌呤)一定与Cytosine(C,胞嘧啶)配对,反之亦然。The term "principle of complementary base pairing" means that in the molecular structure of DNA, since the hydrogen bonds between bases have a fixed number and the distance between the two strands of DNA remains constant, base pairing must follow certain rules , that is, Adenine (A, adenine) must be paired with Thymine (T, thymine), and Guanine (G, guanine) must be paired with Cytosine (C, cytosine), and vice versa.
术语“表达载体”意指在克隆载体基本骨架的基础上增加表达元件(如启动子、RBS、终止子等),使目的基因能够表达的载体。如表达载体pKK223-3是一个具有典型表达结构的大肠杆菌表达载体。其基本骨架为来自pBR322和pUC的质粒复制起点和氨苄青霉素抗性基因。在表达元件中,有一个杂合tac强启动子和终止子,在启动子下游有RBS位点(如果利用这个位点,要求与ATG之间间隔5-13bp),其后的多克隆位点可装载要表达的目标基因。本发明中的目的基因为SEQ ID NO.1所示的多核苷酸序列(a)或(b)中多核苷酸序列的cDNA。The term "expression vector" means a vector that adds expression elements (such as promoter, RBS, terminator, etc.) on the basis of the basic skeleton of the cloning vector to enable the expression of the target gene. For example, the expression vector pKK223-3 is an E. coli expression vector with a typical expression structure. Its basic backbone is the plasmid origin of replication and ampicillin resistance gene from pBR322 and pUC. In the expression element, there is a hybrid tac strong promoter and terminator, and there is an RBS site downstream of the promoter (if this site is used, the distance between ATG and ATG is required to be 5-13 bp), followed by the multiple cloning site The gene of interest to be expressed can be loaded. The target gene in the present invention is the cDNA of the polynucleotide sequence (a) or (b) in the polynucleotide sequence shown in SEQ ID NO.1.
术语“重组宿主细胞”意指包含本发明强启动子RPL和与其对应的终止子的质粒载体的受体细胞,而不管使用何种方法进行插入以产生受体细胞,例如直接吸取、转导或所属领域中已知的其它方法。The term "recombinant host cell" means a recipient cell of a plasmid vector comprising the strong promoter RPL of the present invention and a terminator corresponding thereto, regardless of the method used for insertion to produce a recipient cell, such as direct suction, transduction or Other methods known in the art.
术语“多核苷酸”意指单股或双股形式的脱氧核糖核苷酸、脱氧核糖核苷(DNA)、核糖核苷或核糖核苷酸(RNA)及其聚合物。如本发明中所述二硫键异构酶基因的“DNA”或“cDNA”以及等。除非特定限制,否则所述术语涵盖含有天然核苷酸的已知类似物的核酸,所述类似物具有类似于参考核酸的结合特性并以类似于天然产生的核苷酸的方式进行代谢。除非另外特定限制,否则所述术语也意指寡核苷酸类似物,其包括PNA(肽核酸)、在反义技术中所用的DNA类似物(硫代磷酸酯、磷酰胺酸酯等等)。除非另外指定,否则特定核酸序列也隐含地涵盖其保守修饰的变异体(包括(但不限于)简并密码子取代)和互补序列以及明确指定的序列。特定而言,可通过产生其中一个或一个以上所选(或所有)密码子的第3位经混合碱基和/或脱氧肌苷残基取代的序列来实现简并密码子取代(Batzer等人,Nucleic Acid Res.19:5081(1991);Ohtsuka等人,J.Biol.Chem.260:2605-2608(1985);和Cassol等人,(1992);Rossolini等人,Mol Cell.Probes8:91-98(1994))。其中,本发明中提到的二硫键异构酶基因的cDNA是由二硫键异构酶基因的DNA经转录后获得的RNA逆转录而来。The term "polynucleotide" means deoxyribonucleotides, deoxyribonucleosides (DNA), ribonucleosides or ribonucleotides (RNA) and polymers thereof in single- or double-stranded form. "DNA" or "cDNA" of the disulfide bond isomerase gene as described in the present invention and the like. Unless specifically limited, the term encompasses nucleic acids that contain known analogs of natural nucleotides that have binding properties similar to the reference nucleic acid and are metabolized in a manner similar to naturally occurring nucleotides. Unless specifically limited otherwise, the term also means oligonucleotide analogs, including PNA (peptide nucleic acid), DNA analogs used in antisense technology (phosphorothioate, phosphoramidate, etc.) . Unless otherwise specified, a particular nucleic acid sequence also implicitly encompasses conservatively modified variants thereof (including, but not limited to, degenerate codon substitutions) and complementary sequences as well as the explicitly designated sequences. In particular, degenerate codon substitutions can be achieved by generating sequences in which one or more selected (or all) codons are substituted at position 3 with mixed bases and/or deoxyinosine residues (Batzer et al. , Nucleic Acid Res.19:5081 (1991); Ohtsuka et al., J.Biol.Chem.260:2605-2608 (1985); and Cassol et al., (1992); Rossolini et al., Mol Cell.Probes8:91 -98(1994)). Wherein, the cDNA of the disulfide bond isomerase gene mentioned in the present invention is reverse-transcribed from the RNA obtained after the DNA of the disulfide bond isomerase gene is transcribed.
术语“氨基酸”意指构成蛋白质的基本单位,赋予蛋白质特定的分子结构形态,使他的分子具有生化活性。蛋白质是生物体内重要的活性分子,包括催化新陈代谢的酵素和酶。不同的氨基酸脱水缩合形成肽(蛋白质的原始片段),是蛋白质生成的前体。The term "amino acid" means the basic unit of protein, which endows the protein with a specific molecular structure and makes its molecules biochemically active. Proteins are important active molecules in organisms, including enzymes and enzymes that catalyze metabolism. Different amino acids are dehydrated and condensed to form peptides (the original fragments of proteins), which are the precursors of protein production.
术语“内源蛋白”、“外源蛋白”和“蛋白”意指氨基酸残基的聚合物。所述术语适用于天然产生氨基酸聚合物以及其中一个或一个以上氨基酸残基为非天然编码氨基酸的氨基酸聚合物。The terms "endogenous protein", "exogenous protein" and "protein" mean a polymer of amino acid residues. The term applies to naturally occurring amino acid polymers as well as amino acid polymers in which one or more amino acid residues is a non-naturally encoded amino acid.
附图说明Description of drawings
图1为二硫键异构酶基因Trpdi2及用于Trpdi2表达的载体电泳图。Fig. 1 is the electrophoresis diagram of the disulfide bond isomerase gene Trpdi2 and the vector used for the expression of Trpdi2.
图2为二硫键异构酶基因Trpdi2在大肠杆菌BL21(DE3)诱导表达和镍柱纯化后的二硫键异构酶在SDS聚丙烯凝胶电泳图。Fig. 2 is the electrophoresis pattern of disulfide bond isomerase gene Trpdi2 in Escherichia coli BL21 (DE3) after induced expression and nickel column purification on SDS polypropylene gel.
图3为二硫键异构酶活性测定结果。Figure 3 is the result of disulfide bond isomerase activity assay.
图4为不同浓度DTT处理对里氏木霉纤维素外切酶CBH1活性影响。Figure 4 shows the effect of different concentrations of DTT on the activity of Trichoderma reesei exocellulase CBH1.
图5为二硫键异构酶对还原失活的里氏木霉纤维素外切酶CBH1的活性恢复结果图。Figure 5 is a graph showing the results of disulfide bond isomerase recovery of the activity of reductively inactivated Trichoderma reesei exocellulase CBH1.
具体实施方式Detailed ways
下面结合附图对本发明做进一步的详细说明,以令本领域技术人员参照说明书文字能够据以实施。The present invention will be further described in detail below in conjunction with the accompanying drawings, so that those skilled in the art can implement it with reference to the description.
实施例1:二硫键异构酶基因的克隆Example 1: Cloning of Disulfide Bond Isomerase Gene
(1)Trpdi2基因组DNA的克隆(1) Cloning of Trpdi2 Genomic DNA
根据里氏木霉数据(http://genome.jgi-psf.org/Trire2/Trire2.home.html)中如SEQ ID:1的序列信息,设计相关引物,所述引物序列为:According to the sequence information of SEQ ID: 1 in the Trichoderma reesei data (http://genome.jgi-psf.org/Trire2/Trire2.home.html), design relevant primers, the primer sequence is:
Trpdi2-F:ATGGTCTTGATCAAGAGCCTC,Trpdi2-F: ATGGTCTTGATCAAGAGCCTC,
Trpdi2-R:TCACAGCTCGTCCTTCTGG,Trpdi2-R: TCACAGCTCGTCCTTCTGG,
以-20℃保存的QM9414菌株基因组DNA为模板,进行PCR扩增获得基因全长DNA片段,并将其克隆到pGEM-T载体。Using the genomic DNA of the QM9414 strain stored at -20°C as a template, PCR amplification was performed to obtain the full-length DNA fragment of the gene, which was cloned into the pGEM-T vector.
其中,PCR反应体系为:Wherein, the PCR reaction system is:
PCR反应条件为:The PCR reaction conditions are:
(2)Trpdi2cDNA的克隆(2) Cloning of Trpdi2 cDNA
以-80℃保存的QM9414菌株cDNA为模板,以Trpdi2-F和Trpdi2-R为引物进行PCR扩增获得cDNA片段,并将其克隆到pGEM-T载体。Using the cDNA of QM9414 strain stored at -80°C as a template, the cDNA fragment was amplified by PCR with primers Trpdi2-F and Trpdi2-R, and cloned into pGEM-T vector.
其中,in,
PCR反应体系为:The PCR reaction system is:
PCR反应条件为:The PCR reaction conditions are:
实施例2:二硫键异构酶的表达和活性测定Example 2: Expression and Activity Measurement of Disulfide Bond Isomerase
(1)二硫键异构酶基因Trpdi2的表达载体构建(1) Expression vector construction of disulfide bond isomerase gene Trpdi2
根据二硫键异构酶基因Trpdi2序列设计末端带有酶切位点的引物,以-80℃保存的QM9414菌株cDNA为模板,进行PCR扩增获得含有二硫键异构酶基因Trpdi2序列cDNA的DNA片段,利用NcoI和BamHI双酶切回收的DNA片段及本实验室保藏的pET-24d载体,如图1所示。将两个酶切片段回收连接获得表达载体,将得到的表达载体转化大肠杆菌DH5α。将转化的大肠杆菌DH5α进行测序检测,得到测序检测证明转化正确的DH5α,提取质粒转化大肠杆菌BL21(DE3)。图1中Trpdi2代表双酶切后的二硫键异构酶基因,pET-24d为双酶切的表达载体。According to the sequence of the disulfide bond isomerase gene Trpdi2, primers with restriction sites at the end were designed, and the cDNA of the QM9414 strain stored at -80°C was used as a template to perform PCR amplification to obtain the cDNA containing the sequence of the disulfide bond isomerase gene Trpdi2 DNA fragments, DNA fragments recovered by double digestion with NcoI and BamHI and the pET-24d vector preserved in our laboratory, as shown in Figure 1. The two restriction fragments were recovered and ligated to obtain an expression vector, and the obtained expression vector was transformed into Escherichia coli DH5α. The transformed Escherichia coli DH5α was sequenced and detected, and the sequenced detection proved that the transformed DH5α was correct, and the extracted plasmid was transformed into Escherichia coli BL21(DE3). In Figure 1, Trpdi2 represents the disulfide bond isomerase gene after double digestion, and pET-24d is the expression vector of double digestion.
其中,构建表达载体的连接条件为:Among them, the connection conditions for constructing the expression vector are:
(2)二硫键异构酶TrPDI2的表达(2) Expression of disulfide bond isomerase TrPDI2
挑取含有pET24d-Trpdi2质粒的BL21阳性单菌落,接种至5mL含有卡那霉素的LB培养基中,37℃震荡培养过夜;取1mL菌液接种至100mL含有卡那霉素的LB培养基中,37℃震荡培养至OD600=0.6-0.8;加入IPTG至终浓度0.2mM,16℃、150rpm振荡培养8h。Pick a BL21-positive single colony containing the pET24d-Trpdi2 plasmid, inoculate it into 5 mL of LB medium containing kanamycin, and culture it with shaking at 37°C overnight; take 1 mL of the bacterial liquid and inoculate it into 100 mL of LB medium containing kanamycin , shake culture at 37°C until OD600=0.6-0.8; add IPTG to a final concentration of 0.2mM, shake culture at 16°C, 150rpm for 8h.
(3)二硫键异构酶TrPDI2的纯化(3) Purification of disulfide bond isomerase TrPDI2
将上述震荡培养8h的含有pET24d-Trpdi2质粒的BL21阳性大肠杆菌的LB培养基经离心收集BL21菌体,高压破碎机破碎BL21菌体,离心后分离上清液和沉淀,并将上清液和沉淀分别进行聚丙烯酰氨凝胶电泳SDS-PAGE,检测目的蛋白二硫键异构酶的位置为上清液中比较集中。之后将上清液作为样品进行过镍柱纯化目的蛋白,之后用不同浓度咪唑的洗脱液梯度洗脱目的蛋白,获得纯蛋白后进行浓缩收集获得目的蛋白。如图2所示,为样品、流穿液以及不同浓度咪唑洗脱液中目的蛋白的电泳图,其中,样品为上清液,流穿液为上清液流经镍柱后的过柱液,以及浓度分别为20mM、50mM、100mM、150mM和200mM的咪唑洗脱液,由图2可知,目的蛋白分子量为40kDa,样品、穿流液和不同浓度的咪唑洗脱液中目的蛋白含量都比较高,且不同浓度咪唑洗脱液中只含有目的蛋白,达到了纯化目的蛋白的目的。The LB medium of BL21-positive Escherichia coli containing the pET24d-Trpdi2 plasmid that was cultured for 8 hours by shaking above was collected by centrifugation to collect BL21 cells, and the BL21 cells were crushed by a high-pressure crusher, and the supernatant and precipitate were separated after centrifugation, and the supernatant and The precipitations were subjected to polyacrylamide gel electrophoresis SDS-PAGE, and the position of detecting the disulfide bond isomerase of the target protein was relatively concentrated in the supernatant. Afterwards, the supernatant was used as a sample to purify the target protein through a nickel column, and then the target protein was eluted with gradient eluents of different concentrations of imidazole, and the pure protein was obtained and then concentrated and collected to obtain the target protein. As shown in Figure 2, it is the electrophoresis diagram of the target protein in the sample, the flow-through solution and the eluent of different concentrations of imidazole, wherein the sample is the supernatant, and the flow-through solution is the column solution after the supernatant flows through the nickel column , and concentrations of 20mM, 50mM, 100mM, 150mM, and 200mM imidazole eluents respectively. It can be seen from Figure 2 that the molecular weight of the target protein is 40kDa. High, and different concentrations of imidazole eluate only contain the target protein, to achieve the purpose of purifying the target protein.
(4)二硫键异构酶TrPDI2活性测定(4) Determination of disulfide bond isomerase TrPDI2 activity
将5mg RNaseA溶解在1mL6M盐酸胍、0.14M DTT溶液中,常温放置过夜对RNaseA进行还原失活处理,处理后的RNaseA蛋白通过脱盐柱进行纯化,在存在还原性谷胱甘肽、氧化型谷胱甘肽和底物cCMP的情况下,测定A296的变化,反映RNaseA的复性程度,测定PDI2对RNaseA的反应活性。如图3所示,左侧为用于活性测定实验的TrPDI2蛋白样品SDS聚丙烯酰胺凝胶电泳图,右侧为TrPDI2的二硫键异构酶活性检测结果,其中图3的曲线表示随着反应的进行,反应液在296nm吸光度的变化,反应的是底物cCMP被有活性的核糖核酸酶A作用生成产物的程度。由图3可知,未加入TrPDI2还原失活的RNaseA基本没有活性,而添加TrPDI2可以恢复部分RNaseA的活性,说明TrPDI2具有二硫键异构酶的活性。Dissolve 5mg of RNaseA in 1mL of 6M guanidine hydrochloride and 0.14M DTT solution, place it overnight at room temperature to reduce and inactivate RNaseA, and the treated RNaseA protein is purified through a desalting column. In the case of glycide and substrate cCMP, the change of A296 was measured to reflect the degree of renaturation of RNaseA, and the reactivity of PDI2 to RNaseA was measured. As shown in Figure 3, the left side is the SDS polyacrylamide gel electrophoresis pattern of the TrPDI2 protein sample used in the activity assay experiment, and the right side is the disulfide bond isomerase activity detection result of TrPDI2, wherein the curve in Figure 3 represents the The progress of the reaction, the change of the absorbance of the reaction solution at 296nm, reflects the degree of the substrate cCMP being acted on by the active ribonuclease A to generate the product. It can be seen from Figure 3 that RNaseA that has not been reductively inactivated by adding TrPDI2 has basically no activity, while adding TrPDI2 can restore part of the activity of RNaseA, indicating that TrPDI2 has disulfide bond isomerase activity.
实施例3:二硫键异构酶对于外切葡聚糖酶活性的影响Example 3: Effect of Disulfide Bond Isomerase on Exoglucanase Activity
(1)二硫键对外切葡聚糖酶CBH1蛋白活性的影响(1) Effect of disulfide bond on the activity of exoglucanase CBH1 protein
以里氏木霉发酵液为样品,通过DEAE蛋白层析柱分离纯化到CBH1纯蛋白。以不同浓度的DTT处理CBH1,测定处理1、2、3、4、5、6和18小时后的CBH1蛋白活性,活性测定是以对底物pNPC的活性反应的。如图4所示,左侧为纯化的CBH1蛋白样品的SDS聚丙烯酰胺凝胶电泳图,右侧为DTT处理不同时间之后的CBH1活性结果图,其中三条曲线表示处理不同时间后的CBH1的pNPC酶活性,随着DTT的处理时间,CBH1酶活性下降;随着DTT处理浓度的增加,CBH1酶活性下降更快速。由图4可知CBH1蛋白内部的二硫键对于其酶活性的维持十分重要。Using Trichoderma reesei fermentation liquid as a sample, CBH1 pure protein was separated and purified by DEAE protein chromatography column. CBH1 was treated with different concentrations of DTT, and the activity of CBH1 protein was measured after 1, 2, 3, 4, 5, 6 and 18 hours of treatment. The activity was determined based on the activity of the substrate pNPC. As shown in Figure 4, the left side is the SDS polyacrylamide gel electrophoresis image of the purified CBH1 protein sample, and the right side is the result of CBH1 activity after DTT treatment for different times, and the three curves represent the pNPC of CBH1 after different times of treatment Enzyme activity, with the treatment time of DTT, the enzyme activity of CBH1 decreased; with the increase of DTT treatment concentration, the enzyme activity of CBH1 decreased more rapidly. It can be seen from Figure 4 that the disulfide bond inside the CBH1 protein is very important for the maintenance of its enzymatic activity.
(2)二硫键异构酶对于失活CBH1的活性恢复(2) Recovery of disulfide bond isomerase activity for inactivated CBH1
利用6M盐酸胍、0.14M DTT对CBH1纯蛋白进行失活处理,并利用脱盐柱纯化失活蛋白。以TrPDI2活性测定的体系处理失活的CBH1,并测定处理4、8、12、16、20、24、28、32和36h后的蛋白活性。如图5所示,添加TrPDI2可以部分恢复完全还原失活的CBH1蛋白活性(还原失活的CBH1检测不到酶活性),由图5可知,TrPDI2可以恢复由于二硫键的断裂引起的CBH1蛋白的活性丧失。The pure protein of CBH1 was inactivated with 6M guanidine hydrochloride and 0.14M DTT, and the inactivated protein was purified with a desalting column. The inactivated CBH1 was treated with the TrPDI2 activity assay system, and the protein activity after treatment for 4, 8, 12, 16, 20, 24, 28, 32 and 36 hours was measured. As shown in Figure 5, the addition of TrPDI2 can partially restore the activity of the CBH1 protein that is completely reduced and inactivated (the enzyme activity of the reduced and inactivated CBH1 cannot be detected). loss of activity.
实施例2和实施例3中涉及到的RNaseA和CBH1两种酶在形成空间结构时均形成了数量不等的二硫键,且其维持活性需要正确形成的二硫键,故均属于二硫键必须酶,本发明所述二硫键异构酶TrPDI2对这两种酶的活性恢复都有一定的作用,证明了本发明所述TrPDI2可应用于稳定和恢复二硫键必需酶活性。The two enzymes RNaseA and CBH1 involved in Example 2 and Example 3 all formed different numbers of disulfide bonds when forming the spatial structure, and their activity requires the correct formation of disulfide bonds, so they both belong to disulfide bonds. The disulfide bond isomerase TrPDI2 of the present invention has a certain effect on the recovery of the activities of these two enzymes, which proves that the TrPDI2 of the present invention can be used to stabilize and restore the activity of disulfide bond essential enzymes.
尽管本发明的实施方案已公开如上,但其并不仅仅限于说明书和实施方式中所列运用,它完全可以被适用于各种适合本发明的领域,对于熟悉本领域的人员而言,可容易地实现另外的修改,因此在不背离权利要求及等同范围所限定的一般概念下,本发明并不限于特定的细节和这里示出与描述的图例。Although the embodiment of the present invention has been disclosed as above, it is not limited to the use listed in the specification and implementation, it can be applied to various fields suitable for the present invention, and it can be easily understood by those skilled in the art Therefore, the invention is not limited to the specific details and examples shown and described herein without departing from the general concept defined by the claims and their equivalents.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310651365.6A CN104694560A (en) | 2013-12-04 | 2013-12-04 | Disulfide bond isomerase gene Trpdi2 from Trichoderma reesei and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310651365.6A CN104694560A (en) | 2013-12-04 | 2013-12-04 | Disulfide bond isomerase gene Trpdi2 from Trichoderma reesei and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104694560A true CN104694560A (en) | 2015-06-10 |
Family
ID=53342113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310651365.6A Pending CN104694560A (en) | 2013-12-04 | 2013-12-04 | Disulfide bond isomerase gene Trpdi2 from Trichoderma reesei and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104694560A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10927360B1 (en) | 2019-08-07 | 2021-02-23 | Clara Foods Co. | Compositions comprising digestive enzymes |
US11160299B2 (en) | 2019-07-11 | 2021-11-02 | Clara Foods Co. | Protein compositions and consumable products thereof |
US11279748B2 (en) | 2014-11-11 | 2022-03-22 | Clara Foods Co. | Recombinant animal-free food compositions and methods of making them |
US12096784B2 (en) | 2019-07-11 | 2024-09-24 | Clara Foods Co. | Protein compositions and consumable products thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100144013A1 (en) * | 2007-03-21 | 2010-06-10 | Frits Goedegebuur | Over expression of foldases and chaperones improves protein production |
CN101842479A (en) * | 2007-11-01 | 2010-09-22 | 丹尼斯科美国公司 | Signal sequences and co-expressed chaperones for improving protein production in a host cell |
-
2013
- 2013-12-04 CN CN201310651365.6A patent/CN104694560A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100144013A1 (en) * | 2007-03-21 | 2010-06-10 | Frits Goedegebuur | Over expression of foldases and chaperones improves protein production |
CN101842479A (en) * | 2007-11-01 | 2010-09-22 | 丹尼斯科美国公司 | Signal sequences and co-expressed chaperones for improving protein production in a host cell |
Non-Patent Citations (4)
Title |
---|
GOEDEGEBUUR,F.: "AGY16063.1", 《GENBANK》 * |
HIROYUKI MUKAIYAMA 等: "Overexpression of protein disulfide isomerases enhances secretion of recombinant human transferrin in Schizosaccharomyces pombe", 《APPL MICROBIOL BIOTECHNOL》 * |
UNIPROT: "G0R756,ER-resident thioredoxin protein", 《EBI》 * |
熊向华 等: "二硫键异构酶", 《中国生物工程杂志》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11279748B2 (en) | 2014-11-11 | 2022-03-22 | Clara Foods Co. | Recombinant animal-free food compositions and methods of making them |
US11160299B2 (en) | 2019-07-11 | 2021-11-02 | Clara Foods Co. | Protein compositions and consumable products thereof |
US11800887B2 (en) | 2019-07-11 | 2023-10-31 | Clara Foods Co. | Protein compositions and consumable products thereof |
US11974592B1 (en) | 2019-07-11 | 2024-05-07 | Clara Foods Co. | Protein compositions and consumable products thereof |
US12096784B2 (en) | 2019-07-11 | 2024-09-24 | Clara Foods Co. | Protein compositions and consumable products thereof |
US10927360B1 (en) | 2019-08-07 | 2021-02-23 | Clara Foods Co. | Compositions comprising digestive enzymes |
US11142754B2 (en) | 2019-08-07 | 2021-10-12 | Clara Foods Co. | Compositions comprising digestive enzymes |
US11649445B2 (en) | 2019-08-07 | 2023-05-16 | Clara Foods Co. | Compositions comprising digestive enzymes |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10557130B2 (en) | Arginine deiminase mutant and methods of using the same | |
EP3210997A1 (en) | Agents and methods for the expression and secretion of peptides and proteins | |
KR20240055073A (en) | Class II, type V CRISPR systems | |
CN106497895A (en) | Leucine dehydrogenase mutant, encoding gene, carrier, engineering bacteria and its application | |
Peng et al. | Co-expression of chaperones from P. furiosus enhanced the soluble expression of the recombinant hyperthermophilic α-amylase in E. coli | |
CN104694560A (en) | Disulfide bond isomerase gene Trpdi2 from Trichoderma reesei and application thereof | |
Gao et al. | Three novel Escherichia coli vectors for convenient and efficient molecular biological manipulations | |
US9896679B2 (en) | Fused NHase with improved specific activity and stability | |
CN104130984B (en) | Act on the aflatoxin oxidase of versicolorin | |
CN106282148A (en) | A kind of enzyme agedoite enzyme mutant improved alive | |
WO2009113718A1 (en) | Rna polymerase mutant having improved functions | |
CN108998462B (en) | Escherichia coli expression system for recombinant protein containing manganese ions and its application method | |
CN112921022B (en) | Method for producing 1, 4-butanediamine by using recombinant escherichia coli | |
CN108148852A (en) | A kind of alginate lyase SHA-6 genes and application | |
CN110592119B (en) | A kind of pullulanase derived from Paenibacillus and its gene and application | |
JP2010512168A (en) | Improved expression system for recombinant human arginase I | |
CN109735516B (en) | PIWI protein with specific endonuclease activity guided by nucleotide fragment | |
CN101608179B (en) | Fusion heparinase and coding gene thereof | |
CN103710373B (en) | A kind of prokaryotic fusion expression vector and application thereof | |
JP5258512B2 (en) | DNA polymerase mutant with enhanced exonuclease activity | |
JP2008245604A (en) | Highly efficient thermostable DNA ligase | |
CN112626044B (en) | Mutant and construction method and application thereof | |
CN102911955B (en) | Artificially synthesized human enterokinase gene and its expression and purification method | |
US8137943B2 (en) | Heat-resistant DNA ligase with high reactivity | |
CN108690837B (en) | A method for improving the thermal stability of a multimeric protein and an alcohol dehydrogenase with improved thermal stability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Dongyuan Inventor after: Wang Guokun Inventor after: Lv Pin Inventor after: He Ronglin Inventor after: Chen Shulin Inventor before: Zhang Dongyuan |
|
COR | Change of bibliographic data | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150610 |